杜皮鲁玛
医学
特应性皮炎
中止
皮肤病科
期限(时间)
内科学
物理
量子力学
作者
Celeste M. Boesjes,Esmé Kamphuis,Marlies de Graaf,Lotte S. Spekhorst,Inge Haeck,Lian F. van der Gang,Laura Loman,Nicolaas P. A. Zuithoff,Coco Dekkers,Lisa P. van der Rijst,Geertruida L. E. Romeijn,Albert J. Oosting,Antoni Gostynksi,Anneke M. T. van Lynden‐van Nes,Ron A. Tupker,Anne-Moon van Tuyll van Serooskerken,Annebeth E. Flinterman,Klaziena Politiek,Wouter R. H. Touwslager,Wianda Christoffers
出处
期刊:JAMA Dermatology
[American Medical Association]
日期:2024-08-07
卷期号:160 (10): 1044-1044
被引量:3
标识
DOI:10.1001/jamadermatol.2024.2517
摘要
Limited data are available on the long-term effectiveness and safety of dupilumab for atopic dermatitis (AD) in daily practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI